- Home
- CCG vs ATRA Comparison
CCG vs ATRA Comparison
Compare CCG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CCG | ATRA |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | China | United States |
| Employees | 469 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CCG | ATRA |
|---|---|---|
| Price | $0.47 | $10.41 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 1 | 2 |
| Target Price | ★ $350.00 | $5.00 |
| AVG Volume (30 Days) | ★ 145.2K | 125.3K |
| Earning Date | 05-27-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $567.38 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.47 | $3.92 |
| 52 Week High | $1.54 | $19.15 |
Technical Indicators
Market Signals| Indicator | CCG | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 62.48 |
| Support Level | N/A | $10.50 |
| Resistance Level | $0.77 | $11.35 |
| Average True Range (ATR) | 0.07 | 0.80 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 2.32 | 66.82 |
Price Performance
Historical ComparisonAbout CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).